Pipeline Watch: Phase III Starts With AL001, Beremagene Geperpavec And Relacorilant
Two COVID-19 Vaccines Start Phase III
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
